MoneyWorks4Me

Gufic Biosciences - Quaterly Results

14 Nov 2024 Evaluate
A slight decline in the revenue of Rs. 2041.80 millions was seen for the September 2024 quarter as against Rs. 2148.74 millions during year-ago period.The Net Profit of the company registered a slight decline of -6.18% to Rs. 217.76  millions from Rs. 232.10 millions.Operating profit for the quarter ended September 2024 decreased to 387.38 millions as compared to 397.04 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 2041.80 2148.74 -4.98 4069.92 4098.94 -0.71 8066.66 6906.21 16.80
Other Income 1.14 3.34 -65.87 13.69 12.15 12.67 21.77 25.74 -15.42
PBIDT 387.38 397.04 -2.43 757.75 760.63 -0.38 1480.48 1372.25 7.89
Interest 51.79 44.61 16.10 98.03 85.34 14.87 153.60 82.23 86.79
PBDT 335.59 352.43 -4.78 659.72 675.29 -2.31 1326.88 1290.02 2.86
Depreciation 42.98 42.97 0.02 86.03 85.33 0.82 170.17 222.81 -23.63
PBT 292.61 309.46 -5.44 573.69 589.96 -2.76 1156.71 1067.21 8.39
TAX 74.85 77.36 -3.24 147.34 151.62 -2.82 295.36 270.16 9.33
Deferred Tax -0.15 23.63 -100.63 2.34 32.89 -92.89 31.66 -11.94 -365.16
PAT 217.76 232.10 -6.18 426.35 438.34 -2.74 861.35 797.05 8.07
Equity 100.28 96.94 3.45 100.28 96.94 3.45 100.28 96.94 3.45
PBIDTM(%) 18.97 18.48 2.68 18.62 18.56 0.33 18.35 19.87 -7.63
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..